Safeguard Scientifics, Inc. (SFE) Lowered to “Sell” at ValuEngine

ValuEngine downgraded shares of Safeguard Scientifics, Inc. (NYSE:SFE) from a hold rating to a sell rating in a research report report published on Tuesday.

A number of other equities analysts have also recently issued reports on SFE. Zacks Investment Research raised shares of Safeguard Scientifics from a strong sell rating to a hold rating in a report on Tuesday, July 18th. BidaskClub cut shares of Safeguard Scientifics from a buy rating to a hold rating in a report on Tuesday, July 25th.

Shares of Safeguard Scientifics (NYSE SFE) traded down $0.50 during midday trading on Tuesday, reaching $12.25. 87,400 shares of the company’s stock were exchanged, compared to its average volume of 62,785. The company has a current ratio of 1.03, a quick ratio of 1.03 and a debt-to-equity ratio of 0.45. Safeguard Scientifics has a 1 year low of $10.65 and a 1 year high of $14.40.

Safeguard Scientifics (NYSE:SFE) last issued its earnings results on Thursday, October 26th. The asset manager reported ($0.91) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($1.11) by $0.20. During the same quarter in the prior year, the firm posted ($1.18) earnings per share. analysts anticipate that Safeguard Scientifics will post -4.47 EPS for the current fiscal year.

WARNING: This piece of content was originally reported by Markets Daily and is the sole property of of Markets Daily. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright legislation. The correct version of this piece of content can be read at https://www.themarketsdaily.com/2017/11/15/safeguard-scientifics-inc-sfe-lowered-to-sell-at-valuengine.html.

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. American International Group Inc. raised its holdings in shares of Safeguard Scientifics by 7.2% during the first quarter. American International Group Inc. now owns 12,407 shares of the asset manager’s stock valued at $158,000 after buying an additional 833 shares during the last quarter. KBC Group NV raised its holdings in shares of Safeguard Scientifics by 41.3% during the second quarter. KBC Group NV now owns 13,351 shares of the asset manager’s stock valued at $159,000 after buying an additional 3,904 shares during the last quarter. Nationwide Fund Advisors raised its holdings in shares of Safeguard Scientifics by 7.6% during the second quarter. Nationwide Fund Advisors now owns 14,195 shares of the asset manager’s stock valued at $169,000 after buying an additional 1,006 shares during the last quarter. Alliancebernstein L.P. raised its holdings in shares of Safeguard Scientifics by 27.4% during the second quarter. Alliancebernstein L.P. now owns 14,430 shares of the asset manager’s stock valued at $172,000 after buying an additional 3,100 shares during the last quarter. Finally, Goldman Sachs Group Inc. raised its holdings in shares of Safeguard Scientifics by 12.9% during the first quarter. Goldman Sachs Group Inc. now owns 15,336 shares of the asset manager’s stock valued at $195,000 after buying an additional 1,754 shares during the last quarter. 77.91% of the stock is currently owned by institutional investors.

About Safeguard Scientifics

Safeguard Scientifics, Inc is engaged in providing capital to technology companies within the fields of healthcare, financial services and digital media. The Company holds interest in companies, which it refers to as partner companies. As of December 31, 2016, the Company held interests in 29 non-consolidated partner companies.

Receive News & Ratings for Safeguard Scientifics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply